Major clinical trials, including recent data from the CELIM study, have demonstrated that initially unresectable CRC liver metastases can be surgically removed after combined EGFR inhibition and chemotherapy (CTx), resulting in a better survival of these patients [14, 15]. Here, EGFR is linked to colorectal carcinoma.